St. Jude Children's Research Hospital's Total Therapy Study 16 showed a reduced rate of central nervous system relapse in acute lymphoblastic leukemia, according to results published online Oct. 28 in the Journal of Clinical Oncology.
Robert Winn was named director of Virginia Commonwealth University Massey Cancer Center. The lung cancer and community-based health care expert will begin his role at VCU Dec. 2.
Myles BrownCelina KleerMyles Brown is the recipient of the 2019 AACR Distinguished Lectureship in Breast Cancer Research award at the San Antonio Breast Cancer Symposium, and Celina Kleer will receive the 2019 American Association for Cancer Research Outstanding Investigator Award for Breast Cancer Research at the symposium.
Brian Rini, an expert in genitourinary oncology, kidney cancer and clinical drug development, is joining Vanderbilt-Ingram Cancer Center as the inaugural chief of clinical trials.
The prostate cancer program at the UCLA Jonsson Comprehensive Cancer Center and UCLA Health was awarded a $8.7 million SPORE grant from NCI.
Johns Hopkins Medicine collaborated with Children's National Hospital to open the Johns Hopkins National Proton Center at Sibley Memorial Hospital, providing proton technology for pediatric and adult cancer patients in the District of Columbia.
MD Anderson Cancer Center has named Allyson Hancock Kinzel as senior vice president and chief legal officer, effective Nov. 1.
The Foundation for the National Institutes of Health awarded the second annual Trailblazer Prize for Clinician-Scientists to NCI's James Kochenderfer.
Astellas awarded $200,000 in total grants and resources to winners of the fourth annual Changing Cancer Care prize, a challenge that funds ideas beyond medicine to improve cancer care for patients, caregivers and their loved ones.
President Donald Trump has announced his intention to nominate Stephen M. Hahn to the position of FDA commissioner Nov. 1.
